April 30, 2025
A novel topical formulation of a BRAF inhibitor significantly reduced acneiform rash associated with anti–epidermal growth factor receptor (EGFR) therapies in patients with colorectal cancer, a […]
April 30, 2025
Neoadjuvant treatment with a programmed cell death 1 (PD-1) inhibitor induces clinical complete response and leads to organ preservation in a high proportion of patients with […]
April 30, 2025
(Reuters) – An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung cancer who had already received other treatments for […]
April 30, 2025
In 2017, Stephanie Uy learned that her 22-month-old daughter, Aspen, had stage IV high-risk neuroblastoma. The cancer, which develops from the sympathetic nervous system, is the […]
April 29, 2025
Adding neoadjuvant and adjuvant pembrolizumab to the standard of care significantly improved event-free survival in patients with previously untreated, locally advanced head and neck squamous cell […]
April 29, 2025
TOPLINE: In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in […]
April 28, 2025
TOPLINE: Compared with the general population, adolescent and young adult (AYA) cancer survivors showed elevated risks for death from non-cancer causes, particularly in female patients with […]
April 28, 2025
TOPLINE: Patients with cancer who received prophylactic intravenous (IV) magnesium before starting cisplatin had a lower risk for cisplatin-associated acute kidney injury (AKI) than those who […]
April 28, 2025
TOPLINE: Statin use in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients showed significant survival benefits, with a 45% lower risk for overall mortality […]